Literature DB >> 12435342

Thoracic aortic stents: a combined solution for complex cases.

S Saccani1, F Nicolini, C Beghi, C Marcato, M Uccelli, P Larini, A M Budillon, A Agostinelli, T Gherli.   

Abstract

OBJECTIVES: The combination of endovascular and standard surgical techniques may facilitate the management of complex aortic disease although the long-term durability of this approach needs to be confirmed.
DESIGN: A retrospective review of our experience in the treatment of patients with complex aortic pathology using a combined endovascular and surgical approach.
MATERIALS AND METHODS: Between 1998 and 2001, 27 patients with thoracic aortic aneurysm underwent stent-graft implantation. Eight required combined endovascular and surgical procedure because of complex pathology. In 3 cases, combined repair was carried out for a concomitant abdominal aortic aneurysm or aorto-iliac-femoral occlusive disease. In the other 5 cases, vessel relocation was performed to obtain safe landing zones: left subclavian artery to left carotid artery translocation in 3 patients, celiac trunk to superior mesenteric artery translocation in one and aorto-celiac-mesenteric bypass grafting in one.
RESULTS: One of the 8 patients died on 12th post-operative day of intestinal bleeding and bowel infarction. No neurological sequelae were reported. The other patients are currently well at 11 months mean follow-up time.
CONCLUSIONS: Simultaneous surgical and endovascular procedure is a feasible and may be a valuable adjunct to the treatment of complex aortic and peripheral vessel anatomy.

Entities:  

Mesh:

Year:  2002        PMID: 12435342     DOI: 10.1053/ejvs.2002.1687

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  1 in total

1.  Safety of elective management of synchronous aortic disease with simultaneous thoracic and aortic stent graft placement.

Authors:  Salvatore T Scali; Robert J Feezor; Catherine K Chang; David H Stone; Philip P Goodney; Peter R Nelson; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2012-06-27       Impact factor: 4.268

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.